Prognostic marker of immunohistochemistry-based somatostatin receptors 2 and 5 H-scores in patients with pancreatic neuroendocrine neoplasms

Objective: Pancreatic neuroendocrine neoplasms (pNENs) are histologically classified as well-differentiated, poorly-differentiated, or mixed neuroendocrine-non-neuroendocrine neoplasms. There are unresectable pNENs owing to metastases or invasion in not only functional pNENs but also non-functional....

Full description

Bibliographic Details

Published in:	Endocrine and Metabolic Science
Main Authors:	Satomi Kono, Hidekazu Nagano, Yuki Taki, Takashi Kono, Naoko Hashimoto, Yasuhiro Nakamura, Naoko Inoshita, Masayuki Ohtsuka, Tomoaki Tanaka
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Subjects:	Immunohistochemistry Overall survival Pancreatic neuroendocrine neoplasms Predictive biomarkers Progression free survival Somatostatin receptors
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666396124000207